From: An improved clear cell renal cell carcinoma stage prediction model based on gene sets
Features | Algorithms | Methods | Performance Measures | ||||
---|---|---|---|---|---|---|---|
Sensitivity | Specificity | Accuracy(%) | MCC | AUC | |||
Whole gene set (20,530 genes) | SVM | 10-fold | 0.182 | 0.943 | 63.25 | 0.198 | 0.709 |
Testing | 0.020 | 1.000 | 60.66 | 0.111 | 0.806 | ||
LR | 10-fold | 0.590 | 0.777 | 69.91 | 0.370 | 0.683 | |
Testing | 0.673 | 0.863 | 78.69 | 0.551 | 0.768 | ||
RCSP-set-Weka-Hall (38 genes) | SVM | 10-fold | 0.696 | 0.697 | 70.35 | 0.386 | 0.769 |
Testing | 0.735 | 0.808 | 77.87 | 0.541 | 0.844 | ||
FCBF set (101 genes) | SVM | 10-fold | 0.727 | 0.758 | 74.23 | 0.475 | 0.793 |
Testing | 0.776 | 0.740 | 75.41 | 0.506 | 0.826 | ||
LR | 10-fold | 0.678 | 0.742 | 71.57 | 0.415 | 0.768 | |
Testing | 0.612 | 0.808 | 72.95 | 0.429 | 0.789 | ||
FJL set (23 genes) | Discretization +SVM | 10-fold | 0.680 | 0.868 | 79.27 | 0.562 | 0.852 |
Testing | 0.714 | 0.877 | 81.15 | 0.603 | 0.860 | ||
Discretization + LR | 10-fold | 0.750 | 0.805 | 78.45 | 0.556 | 0.855 | |
Testing | 0.756 | 0.767 | 77.87 | 0.554 | 0.860 | ||
Discretization +SVM | 100 random test sets | 0.710 | 0.788 | 75.64 | 0.496 | 0.831 | |
Discretization + LR | 100 random test sets | 0.647 | 0.876 | 78.32 | 0.542 | 0.842 |